Cargando…
Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysis
The S100B protein is associated with brain damage and a breached blood–brain barrier. A previous pilot study showed that high serum levels of S100B are associated with shorter survival in glioma patients. The aim of our study was to assess the prognostic value in terms of survival and longitudinal d...
Autores principales: | Holla, F. K., Postma, T. J., Blankenstein, M. A., van Mierlo, T. J. M., Vos, M. J., Sizoo, E. M., de Groot, M., Uitdehaag, B. M. J., Buter, J., Klein, M., Reijneveld, J. C., Heimans, J. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020117/ https://www.ncbi.nlm.nih.gov/pubmed/27401156 http://dx.doi.org/10.1007/s11060-016-2204-z |
Ejemplares similares
-
The influence of low-grade glioma on resting state oscillatory brain activity: a magnetoencephalography study
por: Bosma, I., et al.
Publicado: (2008) -
Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide
por: Koekkoek, Johan A. F., et al.
Publicado: (2015) -
Antiepileptic drug treatment in the end-of-life phase of glioma patients: a feasibility study
por: Koekkoek, Johan A. F., et al.
Publicado: (2015) -
Cognitive functioning in glioblastoma patients during radiotherapy and temozolomide treatment: initial findings
por: Hilverda, Karen, et al.
Publicado: (2009) -
Connectomic profile and clinical phenotype in newly diagnosed glioma patients
por: Derks, Jolanda, et al.
Publicado: (2017)